Ovarian Cancer in the Elderly: Time to Move towards a More Logical Approach to Improve Prognosis-A Study from the FRANCOGYN Group.

Date publication

mai 2020

Journal

Journal of clinical medicine

Auteurs

Membres identifiés du Cancéropôle Est :
Pr GRAESSLIN Olivier , Pr AKLADIOS Chérif

Tous les auteurs :
Dion L, Mimoun C, Nyangoh Timoh K, Bendifallah S, Bricou A, Collinet P, Touboul C, Ouldamer L, Azaïs H, Dabi Y, Akladios C, Canlorbe G, Bolze PA, Costaz H, Mezzadri M, Gauthier T, Kridelka F, Chauvet P, Bourdel N, Koskas M, Carcopino X, Raimond E, Graesslin O, Lecointre L, Ballester M, Levêque J, Huchon C, Lavoué V

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/32375360

Résumé

Elderly and/or frail women with ovarian cancer are often undertreated. The aim of the study is to compare the effects of age and frailty on surgical approaches, postoperative complications, and prognosis in elderly women with ovarian cancer.

Mots clés

chemotherapy, elderly, frailty, ovarian cancer, surgery

Référence

J Clin Med. 2020 May 4;9(5):